Filing Details

Accession Number:
0001209191-17-038262
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-07 13:48:55
Reporting Period:
2017-06-06
Filing Date:
2017-06-07
Accepted Time:
2017-06-07 13:48:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1571498 Epizyme Inc. EPZM Pharmaceutical Preparations (2834) 261349956
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1577021 A Robert Copeland C/O Epizyme, Inc.
400 Technology Square
Cambridge MA 02139
President Of Research And Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Commons Stock, Par Value $0.0001 Acquisiton 2017-06-06 2,500 $3.54 34,038 No 4 M Direct
Commons Stock, Par Value $0.0001 Disposition 2017-06-06 2,500 $13.45 31,538 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-06-06 2,500 $0.00 2,500 $3.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
36,050 2023-01-24 No 4 M Direct
Footnotes
  1. The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. This option is fully vested.